Toleranzia

17/06/2025

Symptoms of myasthenia gravis can vary in intensity over the course of a day, and may fluctuate from month to month or year to year.

13/06/2025

June is 𝐌𝐲𝐚𝐬𝐭𝐡𝐞𝐧𝐢𝐚 𝐆𝐫𝐚𝐯𝐢𝐬 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡, an important opportunity to raise awareness about this orphan neuromuscular autoimmune disorder.
At Toleranzia, we’re committed to developing , a disease-specific tolerogen for 𝘮𝘺𝘢𝘴𝘵𝘩𝘦𝘯𝘪𝘢 𝘨𝘳𝘢𝘷𝘪𝘴, designed to re-establish immune tolerance by addressing the root cause of the disease

13/06/2025

This MG Awareness Month, join thousands of others in raising awareness about myasthenia gravis – what it’s like to live with this disease, how it impacts your life, and how the MG Community is fighting for “a world without MG.”

Take action for MG awareness!

* Talk to your neighbors and friends.
* Share your story on social media.
* Create a local fundraiser.
* Put up a yard sign.
* Wear your teal.
* Advocate for research funding.

Find resources and ideas on the MGFA's website at https://myasthenia.org/mg-awareness-month-resources/

08/05/2025

See you there... Let's connect!

04/04/2025

Toleranzia och storägaren Flerie föreslår ett samgående och att Toleranzias tillgångar lever vidare i en onoterad miljö.

07/03/2025

This year’s 2025 theme, , calls on all of us to push forward for gender equality.

🌍 When women rise, we all rise!

At Toleranzia, we are proud to uphold a 50-50 gender balance, fostering an environment where talent and dedication thrive equally. We are committed to revolutionizing autoimmune disease treatment through dedicated innovation and expertise.

Scientific breakthroughs know no gender—only passion, knowledge, and the drive to make a difference.

How will you contribute to an inclusive world? Let’s step forward together and for an inclusive future. 💪



📌 Follow for the latest updates on our mission. 📈

28/02/2025

🌎Today is .

Do you know why it is observed on 28 February? It is the rarest day of the year for the rarest among us. 💙

Do you or a loved one suffer from a rare disease?

At Toleranzia, we are committed to revolutionize autoimmune disease treatment. Our goal is to contribute to a future where rare autoimmune diseases have safer, targeted and effective treatment options.
We go beyond symptom relief- our approach rebalances the immune system to fight autoimmunity at its core. Follow for the latest updates. 🔬

⭐We want to hear from you!
Share your journey in the comments or send us a message.

Your story matters and can inspire others because no one facing a rare disease should feel alone. 💙

16/10/2024

Why is there an urgent need for better treatments?

James Howard, Professor of Neurology, University of North Carolina, and coordinating investigator of Toleranzia’s clinical study, gives his view on the lack of adequate treatments for the .

Why is there an urgent need for better Myasthenia Gravis treatments? James Howard, Professor of Neurology, University of North Carolina, and coordinating…

16/10/2024

Hör Toleranzias vd Charlotte Fribert i intervju från Biostock Studio
https://www.biostock.se/2024/10/toleranzias-vd-om-utveckling-och-kapitalanskaffning/

Toleranzia är aktuellt med lösen i TO4, som kan stärka kassan med 43,4 Mkr. BioStock har intervjuat vd Charlotte Fribert.

14/10/2024

Toleranzia förbereder för att utvärdera i patienter med den sällsynta och autoimmuna nerv-muskelsjukdomen . Studien kommer att samordnas av den framstående kliniska forskaren, James Howard, professor i neurologi och medicin vid University of North Carolina, USA. BioStock - Connecting Innovation & Capital kontaktade honom för att få hans syn på projektet.

Toleranzia förbereder för att utvärdera TOL2. Studien kommer att samordnas av den framstående kliniska forskaren, James Howard.